Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-212523
Filing Date
2018-07-03
Accepted
2018-07-03 17:01:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d591247dsc13da.htm SC 13D/A 32972
  Complete submission text file 0001193125-18-212523.txt   34238
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SC 13D/A

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88058 | Film No.: 18938231
SIC: 2834 Pharmaceutical Preparations